Quick Listen: Scrip’s Five Must-Know Things
Progress, Setbacks And Coronavirus Vaccines
Join us for a quick audio roundup of five useful things to know from Scrip's recent coverage of the global biopharmaceutical industry.
Take a brief audio tour around Scrip’s Five Must-Know Things, in this episode covering major developments in the business week ended 14 August 2020.
Making headlines this time are setbacks and progress for Roche, Bayer's external growth strategy, a controversial coronavirus vaccine approval and an infographic rundown of the world's top-selling drugs.
Stories mentioned in this episode:
(Also see "Roche’s Etrolizumab Failure ‘Removes Big Pipeline Opportunity’" - Scrip, 10 Aug, 2020.)
(Also see "Bayer Back In M&A Mode To Boost Pipeline" - Scrip, 12 Aug, 2020.)
(Also see "Russia Approves First COVID-19 Vaccine" - Scrip, 11 Aug, 2020.)
(Also see "Roche’s Evrysdi Approved For SMA, Priced Below Competitors" - Scrip, 7 Aug, 2020.)
(Also see "The Top 10 Best-Selling Drugs of 2019" - Scrip, 12 Aug, 2020.)